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1. Introduction 
The 2004 Nobel Prize in Chemistry was awarded to Aaron Ciechanover, Avram Hershko, 
and Irwin Rose for their work in discovering the ubiquitin-proteasome system (UPS), as 
reviewed by Herrmann and others (Herrmann et al., 2007). The mechanisms by which 
proteolysis occurs had remained elusive until the late 1970s, when a series of key 
experiments paved the way for a new area of research (Ciechanover et al., 1978; Ciechanover 
et al., 1980b; Hershko et al., 1980). These studies revealed that the majority of protein 
degradation is nonlysosomal and adenosine triphosphate (ATP)-dependent. Most 
importantly, it was also demonstrated that this proteolysis requires at least two components:  
one with protease activity and another in the form of an 8.5-kDa heat-stable protein. These 
elements were later identified as the proteasome and ubiquitin, respectively (Ciechanover et 
al., 1980a; Wilkinson et al., 1980; Hough et al., 1986; Waxman et al., 1987; Arrigo et al., 1988). 
Substrates of the UPS include many short-lived regulatory proteins in addition to misfolded 
and defective proteins (Dahlmann, 2007; Naiki & Nagai, 2009; Xie, 2010). Conserved from 
Archaea to humans, the UPS is thought to be responsible for degrading approximately 90% 
of nuclear and cytoplasmic proteins (Magill et al., 2003). Through regulation of protein 
expression, the UPS controls processes such as protein homeostasis, cell-cycle, cell division, 
cellular differentiation, apoptosis, signal transduction, gene expression, immunity, and 
DNA repair (Magill et al., 2003; Finley, 2009; Liggett et al., 2010; Shabek & Ciechanover, 
2010; Xie, 2010). Although much focus on this system revolves around its proteolytic 
function and regulation, members of the UPS also play non-proteolytic roles in 
transcription, membrane trafficking, protein kinase activation, chromatin dynamics, and 
DNA repair (Chen & Sun, 2009; Xie, 2010).  
The UPS plays one of the central roles in pathology and disease, and it has become the target 
of several newer therapeutic modalities. In patients with some forms of cardiac dysfunction, 
neurodegeneration, autoimmune disease, and viral infections, proteasome activity and/or 
expression is diminished (Magill et al., 2003; Dahlmann, 2007; Naiki & Nagai, 2009). 
Conversely, in some cancer patients and patients with cachexia, an increase in proteasome 
expression has been observed. According to the idea that this increase in proteosome 
activity is a potential therapeutic target, proteosome inhibitors are developed and isolated 
from natural products (Orlowski & Kuhn, 2008; Groll et al., 2009; Huang & Chen, 2009). 
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Most notably, bortezomib (Velcade, PS-341) is the first FDA approved proteasome inhibitor 
and has been used with some success in the treatment of multiple myeloma and mantle cell 
lymphoma patients (Palombella et al., 1998; Hideshima et al., 2001; Russo et al., 2007). 
This chapter is focused on the UPS and its interaction with DNA repair. DNA can be 
damaged by a wide variety of environmental stresses (ionizing radiation, Ultraviolet (UV) 
radiation, chemicals) and endogenous cellular metabolites; these DNA damages include 
base-damage lesions, single-strand breaks (SSBs), double-strand breaks (DSBs), DNA-DNA 
and DNA-protein crosslinks, as well as other adducts (Sharova, 2005a; Huang & D'andrea, 
2006). Consequently, cells have evolved a number of DNA repair pathways in order to 
remove or mend these lesions quickly and efficiently to preserve genomic integrity. The 
connection between DNA repair and the UPS was first revealed when Jentsch and 
colleagues showed that the DNA repair gene Rad6 encodes a ubiquitin-conjugating enzyme 
(Jentsch et al., 1987). Following this finding, the study of UPS-regulated DNA repair has 
expanded immensely. Specifically, this chapter will revolve around the UPS as it relates to 
the nucleotide excision repair (NER), base excision repair (BER), mismatch repair (MMR), 
double-strand break (DSB) repair, post-replication repair (PRR), and Fanconi anemia (FA) 
pathways. We will explore the extent to which representative DNA repair proteins of these 
pathways directly interact with members of the UPS and depend upon the proteolytic and 
non-proteolytic roles of the UPS. Finally, despite the fact that the mechanisms of action of 
proteasome inhibitors are not wholly understood (Drexler, 1997), current evidence suggests 
that DNA repair pathways are key targets of bortezomib treatment.      
2. The ubiquitin-proteasome system 
The UPS contains both substrate-recruiting and substrate-degrading machinery (Dahlmann, 
2007). The central element of this intricate system, the proteasome, is a highly abundant and 
stable cellular protein complex (Liggett et al., 2010). A number of proteasome-associated 
proteins have been identified, which may either enhance or suppress UPS-mediated 
proteolysis, and yeast genetics has contributed greatly to the understanding of the UPS by 
facilitating its manipulation (Finley, 2009).    
2.1 Structure of the proteasome  
The 2.5-MDa proteasome can exist in several forms organized into two main subcomplexes:  
the 28-subunit core particle (CP or 20S proteasome) and the 19-subunit regulatory particle 
(RP, 19S proteasome, or PA700) (Finley, 2009; Xie, 2010). The 20S proteasome is a barrel-like 
structure composed of four stacked heptameric rings. The outer rings consist of one of seven 
unique alpha-subunits and the inner rings are composed of one of seven unique beta-
subunits, a configuration that may be represented as: ┙1-7┚1-7┚1-7┙1-7 (Groll et al., 1997; Navon 
& Ciechanover, 2009). The largest dimensions of the interior of the 20S proteasome are 
approximately 100 Å axially and 60 Å orthogonally (Finley, 2009). However, crystal 
structures of the 20S proteasome show that the entry ports of the alpha-subunits are as 
narrow as 10-13 Å (Groll et al., 1997), which helps to prevent spontaneous protein 
degradation.  
The 20S proteasome supports three main catalytic activities:  (1) the ┚1-subunit has caspase-
like activity and cleaves peptide bonds after acidic residues; (2) the ┚2-subunit possesses 
trypsin-like activity and cleaves after basic residues; and (3) the ┚5-subunit carries 
chymotrypsin-like activity and cleaves after large, hydrophobic residues (Orlowski & Wilk, 
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2000). The catalytic subunits of the 20S proteasome degrade proteins into a heterogeneous 
mixture of peptides rather than into single amino acids (Kisselev et al., 1999; Goldberg et al., 
2002). Proteasomal inhibitors interfere with these activities to various degrees and with 
specificities for one or more of the main catalytic activities (Groll et al., 2009).  
The 19S proteasome is attached to one or both ends of the 20S proteasome, and the resulting 
complex is known as the 26S proteasome. Although no crystal structure for the 19S 
proteasome has yet been solved, it is currently believed that the 19S proteasome can be 
separated into two additional subcomplexes:  the base and the lid. The base is composed of 
six AAA ATPase (ATPases Associated with diverse cellular Activities) subunits (Rpt1-6 in 
Saccharomyces cerevisiae) as well as three non-ATPase subunits (Rpn1, Rpn2, and Rpn13 in S. 
cerevisiae). The lid includes at least nine non-ATPase subunits (Rpn3, Rpn5-9, Rpn11, Rpn12, 
and Rpn15 in S. cerevisiae). Additionally, the yeast protein Rpn10 appears to stabilize the 
connection between the base and the lid (Finley, 2009; Xie, 2010).    
2.2 Function of the UPS 
Protein substrates targeted for proteasomal degradation must first be tagged by ubiquitin, a 
highly conserved 76 amino acid protein. This process is carried out by the concerted 
activities of three categories of enzymes:  a ubiquitin-activating enzyme (E1), a ubiquitin-
conjugating enzyme (E2), and a ubiquitin-protein ligase (E3) (Dahlmann, 2007; Chen & Sun, 
2009; Navon & Ciechanover, 2009; Shabek & Ciechanover, 2010). According to recent counts, 
humans have genes for two E1, roughly 40 E2, and approximately 600 E3 enzymes (Chen & 
Sun, 2009; Hofmann, 2009). In the first step of the reaction, E1 activates the ubiquitin 
polypeptide in an ATP-dependent process, and the activated ubiquitin molecule is 
subsequently transferred onto E2 by a thioester bond. E3 can then bind the activated 
ubiquitin to a substrate protein; the high degree of specificity of this enzyme dictates the 
specificity by the UPS (Magill et al., 2003). An isopeptide bond is formed between the C-
terminal glycine (G76) of ubiquitin and the i-amino group of a lysine on the targeted 
protein. Next, a polyubiquitin chain is generated through repetition of this process on the 
ubiquitin molecules themselves. Although ubiquitin contains seven lysine residues (K6, K11, 
K27, K29, K33, K48, and K63), new ubiquitin moieties are conjugated most often to K48 of 
the previously attached ubiquitin molecule (Varshavsky, 1997; Hershko et al., 2000; 
Schwartz & Ciechanover, 2009). A chain of at least four ubiquitin proteins linked through 
K48 is recognized by the 26S proteasome for degradation (Figure 1). It appears as though 
K48 has a rather exclusive role in the formation of ubiquitin-mediated degradation signals; 
the other six lysines of ubiquitin can play either proteolytic or non-proteolytic roles when 
engaged to form polyubiquitin chains (Chen & Sun, 2009).  
Ubiquitin-like proteins (UBLs) are structurally similar to ubiquitin and utilize a comparable 
enzyme cascade consisting of UBL-activating (E1), UBL-conjugating (E2), and UBL-ligase 
(E3) enzymes (Huang & D'andrea, 2006). Among UBLs, SUMO (small ubiquitin-like 
modifier) and NEDD8 (neuronal-precursor-cell-expressed developmentally downregulated 
protein-8) are the best characterized. SUMO exists in at least four mammalian isoforms 
(SUMO-1,2,3,4). The process of sumoylation, which is ATP-dependent and generally has 
nondegradative functions, is reversibly executed by SUMO isopeptidases (Johnson, 2004). 
NEDD8 (Rub1 in S. cerevisiae) also does not directly signal proteolysis but rather regulates 
E3 ubiquitin-protein ligases and covalently binds to the Cullin family of E3 complexes (Hori 
et al., 1999). 
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Entry of substrates into the multicatalyic 20S proteasome is regulated and stimulated by the 
19S proteasome. Rpn11 and Rpn13 of the 19S proteasome, and three proteasome-associated 
proteins, Rad23, Dsk2, and Ddi1, serve as ubiquitin receptors (Finley, 2009). These latter 
proteins weakly bind to the proteasome and are termed UBL/UBA shuttle proteins due to 
their ubiquitin-like (UBL) and ubiquitin-associated (UBA) domains (Finley, 2009). Prior to 
degradation, the ubiquitin moieties must be removed and the protein substrates unfolded. 
Rpn11 in yeast (Poh1 in humans) serves as a deubiquitinating enzyme (DUB) in the presence 
of ATP and cooperates with two other deubiquitinases, Upb6 and Uch37 (Usp14 in 
mammals) (Finley, 2009). Mammals possess about 90 known DUBs for cleaving 
polyubiquitin chains or for removing ubiquitin from protein substrates (Chen & Sun, 2009; 
Hofmann, 2009). Although substrate unfolding and translocation are not completely 
understood, it is currently believed that the six ATPases of the 19S base unfold target 
proteins and open the gate of the 20S so that substrate proteins may reach the proteolytic 
sites (Finley, 2009; Shabek & Ciechanover, 2010). 
 
 
Fig. 1. Schematic representation of UPS-mediated protein regulation. A protein substrate 
(orange) is tagged with a polyubiquitin chain upon the activities of E1, E2, and E3 enzymes. 
Substrates modified by a K48-linked polyubiquitin chain are processed and degraded by the 
26S proteasome, consisting of a 20S core and 19S regulatory particles. Oppositely, K63-
linkages are attributed to non-proteolytic functions and can allow for functional alterations 
of the tagged substrate.  
2.3 The UPS and general repair proteins 
Two proteins closely linked with DNA repair in general and regulated by the UPS are p53 
and PCNA. In both cases, their UPS regulation can be either proteolytic or non-proteolytic 
(Coutts et al., 2009; Ulrich, 2009). p53 is regulated by the UPS in a way that prevents 
unnecessary cell death or cell-cycle arrest (Stehmeier & Muller, 2009). p53 interacts with the 
19S proteasome in vitro and in vivo (Zhu et al., 2007) and can be both mono- or 
polyubiquitinated (Stehmeier & Muller, 2009). Mdm2, a ubiquitin-protein ligase, promotes 
the ubiquitination and consequent degradation of p53 as well as the conjugation of NEDD8 
(Zhang & Xiong, 2001; Xirodimas et al., 2004). NEDD8 conjugation appears to weaken the 
inhibition of p53, and this ubiquitination and NEDDylation of p53 are independently 
regulated upon DNA damage (Xirodimas et al., 2004). Additionally, both p53 and Mdm2 are 
modified by SUMO-1 (Chen & Chen, 2003). Only a small fraction of p53 is sumoylated, and 
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the possible role of p53 sumoylation in degradation and DNA repair is still being 
investigated (Stehmeier & Muller, 2009).  
Similarly, proliferating cell nuclear antigen (PCNA), a processivity clamp for the replicative 
and repair DNA polymerases, is a target of the UPS (Paunesku et al., 2001; Ulrich, 2009). In 
yeast, PCNA is modified by SUMO at the beginning of S-phase (Papouli et al., 2005; Pfander 
et al., 2005); however, in response to DNA damage, PCNA is monoubiquitinated in a 
Rad6/Rad18 dependent manner (Hoege et al., 2002; Lee & Myung, 2008). Further 
modification with a K63-linked polyubiquitin chain can then occur pending the interaction 
of Rad5, a ubiquitin-protein ligase, and Ubc13-Mms2, a ubiquitin-conjugating dimer 
(Hofmann, 2009). Monoubiquitinated and polyubiquitinated PCNA proteins are involved in 
different DNA repair mechanisms. Proteins PTIP/Swift, an adapter for checkpoint kinases 
ATM and ATR, and ubiquitin specific protease 1 (USP1) deubiquitinate PCNA (Huang et al., 
2006; Ulrich, 2009). Finally, tight regulation of PCNA ubiquitination, keeping ubiquitinated 
PCNA at low levels in undamaged cells, prevents the recruitment of translesion synthesis 
(TLS) polymerases, an event that could lead to mutagenesis (Lee & Myung, 2008). For more 
on PCNA, see section 7.  
3. Nucleotide excision repair  
Nucleotide excision repair (NER) is an evolutionarily conserved, multistep mechanism 
responsible for removing bulky chemical adducts and UV-induced photoproducts from 
DNA (Sharova, 2005a). NER can be divided into repair of overall genomic DNA [global 
genome repair (GGR)] and repair of actively transcribing genes [transcription-coupled 
repair (TCR)] (Mueller & Smerdon, 1996). Approximately 30 proteins participate in NER. In 
this relatively error-free repair process, sites of DNA damage are first recognized and bound 
by a multi-protein complex. The damaged strand is then cleaved several nucleotides away 
from the 5’ and 3’ ends of the affected oligonucleotide. Upon removal of this fragment, the 
resulting ~30 nucleotide gap is filled by DNA polymerases h and i in a PCNA-dependent 
manner, and a DNA ligase covalently attaches the 3’ end of the newly synthesized strand to 
the flanking DNA (Lommel et al., 2000). Defects in NER are associated with diseases such as 
Xeroderma Pigmentosum, Cockayne’s Syndrome, and Trichothiodystrophy (Bergoglio & 
Magnaldo, 2006; Leibeling et al., 2006).    
3.1 Nucleotide excision repair enzymes and the UPS  
In mammalian cells, the first step of NER initiation after damage involves the Damaged-
DNA binding protein (DDB) complex that recognizes sites of complex adducts, including 
those induced by UV radiation (Stoyanova et al., 2009; Iovine et al., 2011). Two protein 
members of this complex, DDB1 and DDB2, associate with the Cullin 4A (Cul4A) ubiquitin 
E3 complex, which has been shown to polyubiquitinate Xeroderma pigmentosum C protein 
(XPC) (Stoyanova et al., 2009; Iovine et al., 2011). DDB1 regulates cyclin-dependent kinase 
inhibitor 1B (p27) levels after low-dose UV irradiation (Iovine et al., 2011). DDB2 associates 
with COP9 Signalosome complex (CSN), which has structural homology to the 19S 
proteasome (Groisman et al., 2003). DDB2 also regulates levels of cyclin-dependent kinase 
inhibitor 1 (Cip1 or p21) and phospho-p53 through the UPS (Stoyanova et al., 2009). 
Interestingly, DDB2 is targeted by Cul4A and polyubiquitinated after UV irradiation 
(Bergink et al., 2007; Stoyanova et al., 2009; Iovine et al., 2011). Therefore, both DDB2 and 
XPC are downregulated by Cul4A, but protein degradation in this situation promotes a 
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more efficient DNA repair, as explained further later. No homolog of DDB2 is found in 
yeast, but a comparable E3 enzyme complex containing Rad16, Rad7, Cul3, and Elc1 is 
linked to GGR in yeast (Gillette et al., 2006; Dantuma et al., 2009).  
Following UV irradiation, ubiquitin and SUMO-1 modify XPC in a manner dependent on 
DDB2 and XPA (Wang et al., 2005b). XPC in mammalian cells and Rad7 and Rad16 in yeast 
are required for GGR (Chen et al., 2007). Cockayne syndrome complementation group A 
and B proteins (CSA and CSB) in mammals and Rpb9 and Rad26 (the homologue of CSB) in 
yeast are required for TCR (Chen et al., 2007). CSA and CSB are also necessary for 
ubiquitination of Rpb1, the largest subunit of RNA polymerase II (Pol II) (Chen et al., 2007). 
When DNA damage causes DNA Polymerase II to become stalled, Rpb1 is 
polyubiquitinated and degraded by the 26S proteasome (Ribar et al., 2006; Chen et al., 2007). 
It does not appear as if the whole Pol II complex is degraded (Ribar et al., 2006), and Rpb9, 
another subunit of Pol II, mediates the ubiquitination of Rpb1 in response to UV radiation 
(Chen et al., 2007; Daulny & Tansey, 2009). Conversely, the DUB Ubp3 deubiquitinates Pol II 
and prevents its degradation (Mao & Smerdon, 2010).  
Different types of histone modifications are associated with DNA repair, such as 
monoubiquitination of histone H2A following UV-damage (Bergink et al., 2006). 
Ubiquitinated H2A (uH2A) is the most common modification of histones in higher 
eukaryotes, and uH2A foci formation requires either functional GGR or TCR (Zhu et al., 
2009). The E3 enzyme Cul4A-DDB has also been shown to ubiquitinate histones H3 and H4 
in order to positively regulate NER (Zhu et al., 2009). Histone ubiquitination could play a 
role in chromatin remodelling and is dependent on RING2, an E3 enzyme, and ATR-kinase 
(Bergink et al., 2006). The pivotal yeast NER protein Rad4, the yeast homologue of XPC, is 
involved in this process. Rad4 binds to Snf5 and Snf6 of the Swi/Snf chromatin-remodelling 
complex (Gong et al., 2006), which correlates with UV-induced chromatin remodelling; this 
event could induce DNA to be more accessible to repair proteins (Dantuma et al., 2009). 
Interestingly, proteasome inhibitors such as lactacystin (LC) and N-acetyl-leucyl-leucyl-
norleucinal (ALLnL) deplete free cellular ubiquitin, thereby negatively affecting protein 
dynamics of histones, and promote chromatin condensation (Mimnaugh et al., 2000).  
Yeast protein Rad23 is involved in both NER pathways:  GGR and TCR (Mueller & 
Smerdon, 1996). Rad23 itself is not degraded by the 26S proteasome because it lacks an 
initiation region for the proteasome to engage and unfold it (Fishbain et al., 2011). However, 
Rad23 has been shown to contact proteins Rpt1 (Cim5), Rpt4 (Sug2), Rpt6 (Cim3/Sug1), 
Rpn1, and Rpn10 (S5a) of the 19S proteasome (Waters et al., 1993; Motegi et al., 2009), 
perhaps to recruit it to sites of DNA damage (Russell et al., 1999). The N-terminal domain of 
Rad23 (the UbL domain) resembles ubiquitin, which enables it to interact with the 26S 
proteasome directly (Watkins et al., 1993; Schauber et al., 1998). Notably, Rad23 has 22% 
identical and 43% similar amino acid residues compared to ubiquitin from S. cerevisiae 
(Watkins et al., 1993; Schauber et al., 1998). Deletion of the UbL domain impairs Rad23 
function, leading to UV-sensitivity and a 50% decrease of NER activity in yeast (Watkins et 
al., 1993; Russell et al., 1999). This effect is reversed, however, upon substitution of the UbL 
domain with the sequence of ubiquitin (Watkins et al., 1993). E1-ubiquitin and E2-ubiquitin 
thioester intermediate formation does not appear to be affected by Rad23, but the presence 
of Rad23 remarkably stabilizes proteins in vivo and inhibits multi-ubiquitin chain assembly 
in vitro (Ortolan et al., 2000). The two UBA regions of Rad23 participate in noncovalent 
interactions with ubiquitin, and loss of both UBA regions does not allow Rad23 to block 
assembly of multi-ubiquitin chains on protein substrates (Chen et al., 2001). Interestingly, 
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the C-termini of the human homologues to Rad23, hHR23A and hHR23B, contain a stretch 
of amino acids homologous to E2 enzymes (van der Spek et al., 1996; Masutani et al., 1997).  
The C-terminus of Rad23 binds with high affinity to Rad4 (Mimnaugh et al., 2000). 
Rad23/Rad4 complexes govern damage recognition and bind UV-irradiated DNA (Guzder 
et al., 1998; Jansen et al., 1998; Guzder et al., 1999); loss of Rad4 leads to severe UV-
sensitivity (Ortolan et al., 2000). Rad23 can regulate polyubiquitination of Rad4 in vivo and 
delay its degradation by the 26S proteasome (Lommel et al., 2002). The Rad4 binding 
domain (R4B) of Rad23 is also sufficient to stabilize Rad4 and enable NER in yeast strains 
lacking Rad23 (Ortolan et al., 2004). Nevertheless, in a Rad23 null strain, overexpression of 
Rad4-hemagglutinin does not rescue the impaired repair of cyclobutane pyrimidine dimers 
(CPDs) (Lommel et al., 2002). Rad23 may protect Rad4 from degradation so that it can 
participate in NER, but Rad23 may also play proteolytic roles in other pathways (Ortolan et 
al., 2004). Essentially, optimal NER necessitates two distinct functions of Rad23; both 
Rad23/proteasome and Rad23/Rad4 interactions are required for maximum UV-resistance 
(Ortolan et al., 2004).  
Other yeast enzymes, Rad7 and Rad16, are also involved in UPS regulation of NER. These 
proteins are members of the nucleotide excision repair factor 4 (NEF4) complex, which bears 
E3 activity and regulates Rad4 levels (Ramsey et al., 2004). The DUB Upb3 promotes 
degradation of Rad4, which leads to a negative regulation NER; conversely, inactivation of 
Upb3 stabilizes Rad4 (Mao & Smerdon, 2010). 
Ubiquitination is necessary for NER, since E1 enzyme inactivation exerts a negative 
influence on NER in mammalian cells (Wang et al., 2005a). However, much debate 
surrounding NER and the UPS still exists, revolving around the question of whether UPS-
mediated modifications leading to proteolysis (a proteolytic role of the UPS) are more or less 
important for NER than the modifications (ubiquitination, sumoylation, etc.) that do not 
lead to protein degradation (a non-proteolytic role of the UPS). For example, Rad23 is not 
degraded by the proteasome, and this suggests that it has a non-proteolytic role (Watkins et 
al., 1993). Antibodies against the ATPases of the 19S have been shown to measurably lower 
NER activity, but mutations in 20S subunits that severely curb proteolysis and incubation 
with proteosome inhibitor LC do not appear to change NER activity (Russell et al., 1999; 
Gillette et al., 2001). Also, efficient NER in yeast relies on two mechanisms related to the 
necessity of de novo protein synthesis, neither of which entails proteolytic behavior (Gillette 
et al., 2006). Rad23 and the 19S proteasome regulate one such pathway, independently of de 
novo protein synthesis. Another pathway involving Rad4 ubiquitination by a Rad7-
containing E3 ligase depends on de novo protein synthesis to restore Rad4 to baseline levels 
such as they were prior to DNA damage (Gillette et al., 2006). All these findings stress a 
connection between NER and non-proteolytic behavior of the UPS (Gillette et al., 2006).  
However, NER has been shown to be increased in yeast strains with mutations in genes 
encoding the 26S proteasome (Lommel et al., 2002). Proteosome inhibitors LC and ALLnL 
interfere with removal by NER of cisplatin-damaged DNA and decrease mRNA levels of the 
excision nuclease Ercc-1 in ovarian cancer cells (Mimnaugh et al., 2000). Treatment of 
normal human fibroblasts with proteosome inhibitors MG132 or LC decreases repair of 
CPDs (Wang et al., 2005a). Overexpression of hSug1, one of the six ATPases of the 
mammalian 19S proteasome, competes with endogenous 19S proteasomes for substrates and 
negatively affects NER (Wang et al., 2005a). In yeast, conditional proteasome mutants of 
Rpt1 and Rpt6 exhibit faster NER in a single gene repair study (Lommel et al., 2000). 
Similarly, overexpression of Rad4 results in increased NER of the transcribed and non-
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transcribed strands of the damaged gene. Therefore, proteosome subunit overexpression has 
an effect similar to overexpression of the NER protein Rad4, which results in increased GGR 
and TCR (Lommel et al., 2000).  
Ultimately, this apparent discrepancy could stem from the use of different model systems 
because NER proteins and processes differ among different organisms (Wang et al., 2005a). 
The exact role(s) of the 26S proteasome in NER remain somewhat obscured. There is no 
consensus on whether the 26S proteasome plays excitatory and/or inhibitory roles in NER, 
nor is the balance between the roles of Rad23 in DNA repair and proteolysis fully 
understood (Dantuma et al., 2009). It is unclear whether Rad23 is ubiquitinated itself, and if 
so, what is the significance of that modification (Dantuma et al., 2009). Nevertheless, 
evidence of “protein sharing” between the UPS and NER suggests a functional connection 
that is deeper than our present understanding of this system. 
4. Base excision repair  
The base excision repair (BER) pathway regulates removal of damaged bases, 
apurinic/apyrimidinic (AP) sites, and single-strand breaks (SSBs) induced by UV radiation, 
ionizing radiation, oxidative stressors, and alkylating agents (Dalhus et al., 2009; Wilson et 
al., 2010). For every double-stranded DNA break (DSB), cells sustain hundreds of SSBs; 
consequently, BER activity in cells is perpetually engaged. BER can be separated into long-
patch repair and short-patch repair, dependent upon the type of lesion incurred as well as 
the expression levels of BER proteins (Memisoglu & Samson, 2000; Wilson et al., 2010). The 
most fundamental steps of BER include damaged base recognition and removal by DNA 
glycosylases, strand cleavage by an AP endonuclease, incised strand processing, DNA 
synthesis, and ligation (Sharova, 2005a). Processing of gaps in mammalian DNA involves a 
DNA polymerase (primarily Pol ┚), DNA ligase III┙, and X-ray crosscomplementing group-
1 protein (Xrcc1) (Parsons et al., 2010). Importantly, the BER, NER, and MMR activities can 
overlap in protection against DNA damage (Wilson et al., 2010), sharing proteins such as 
Rad4. Dysfunctional BER can lead to chromosomal rearrangements and cell death, and 
defects/knock-out animals for BER genes are often associated with embryonic lethality 
(Wilson & Thompson, 1997).      
4.1 Base excision repair and the UPS   
While poly (ADP-ribose) polymerase-1 (PARP-1) does not appear to play an enzymatic role 
in BER, it is the molecule that recognizes DNA damage repaired by BER. Moreover, PARP 
inhibition delays repair of SSBs in Xrcc1-deficient cells (Strom et al., 2010) and protects SSBs 
from becoming DSBs, thereby ensuring that the SSBs may be repaired by BER proteins 
(Woodhouse et al., 2008). PARP-1 has been shown to be polyubiquitinated and modified by 
SUMO-1 and SUMO-3 in vitro and in vivo (Wang et al., 2008; Messner et al., 2009). 
Polyubiquitination of PARP-1 requires proteasomal inhibition, indicating that it is a target of 
the 26S proteasome (Wang et al., 2008). In a yeast two-hybrid screen, PARP was found to 
interact with hUbc9, the human protein homologous to Ubc9, a yeast E2 enzyme (Masson et 
al., 1997). hUbc9 mRNA has been shown to increase at the beginning of S-phase, suggesting 
that hUbc9 is involved in degradation of cyclins, as Ubc9 is in yeast (Masson et al., 1997).  
The transcription of yeast DNA glycosylase genes MAG1, NTG1, and NTG2 is co-regulated 
with proteasomal genes and modulated by transcription factor Rpn4, a negative regulator of 
the proteosome (Jelinsky et al., 2000; Hanna & Finley, 2007). Another BER DNA glycosylase, 
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thymine-DNA glycosylase (TDG), binds SUMO-1 covalently and noncovalently (Takahashi 
et al., 2005). Covalent modification of TDG with SUMO-1 or SUMO-3 reduces its affinity for 
DNA (Hardeland et al., 2002b). The enzymatic properties of TDG change upon sumoylation; 
GT mismatch processing is repressed, whereas GU processing augments. TDG 
sumoylation facilitates its dissociation from AP sites, allowing for AP endonuclease entry 
(Hardeland et al., 2002b). Mechanistically, TDG changes conformation when it contacts 
DNA, binding tightly to mismatches; conjugation of SUMO-1 to the C-terminal domain of 
TDG induces another conformational change in the N-terminus of TDG so that it can 
dissociate from the AP sites (Steinacher & Schar, 2005b). TDG sumoylation does not seem to 
affect polyubiquitination and degradation of TDG (Hardeland et al., 2007).  
While TDG levels are highest during G2/M- and G1-phases of the cell-cycle but taper 
during S-phase, UNG2, a uracil-DNA glycosylase, is upregulated during S-phase 
(Hardeland et al., 2007). Thus, TDG and UNG2 play non-redundant, alternating roles. The 
UPS regulates these precise fluctuations in TDG and UNG2 protein levels; for example, 
treatment with the proteasomal inhibitor MG132 measurably increases TDG levels 
(Hardeland et al., 2007).  
Interestingly, a key role of ubiquitination in BER is to modify the proteins that are not 
members of an active BER complex so that they may be rapidly degraded, which allows 
clearance of access for BER proteins. CHIP, an E3 enzyme, is responsible for turnover of BER 
proteins such as Xrcc1, which acts as a scaffold for directing assembly of BER complexes at 
sites of DNA damage, and Pol  (Parsons et al., 2008b). Although CHIP appears to be the 
principal E3 in this process, other E3 enzymes may be involved as well. Phosphorylation of 
Xrcc1 by casein kinase 2 (CK2) appears to be necessary for efficient BER; this 
phosphorylation improves the stability of Xrcc1 by protecting it from ubiquitination 
(Parsons et al., 2010). In addition, Xrcc1 recruits JWA to sites of damage, and loss of JWA 
leads to Xrcc1 degradation by the UPS (Wang et al., 2009). Xrcc1 is also modified by SUMO-
1 (Gocke et al., 2005; Moschos & Mo, 2006).  
5. Mismatch repair 
The mismatch repair (MMR) system corrects noncomplementary base pairs that escape the 
proofreading activity of DNA polymerases ├ and ┝ in DNA replication (Jiricny, 1998; 
Sharova, 2005b). The process begins with mispair recognition by the hMutS┙ complex, a 
heterodimer of hMSH2 and hMSH6, or by the complex hMutS┚, a heterodimer of hMSH2 
and hMSH3 (Modrich & Lahue, 1996; Jiricny, 1998; Kolodner & Marsischky, 1999). Another 
complex, hMutL┙, a heterodimer of hMLH1and hPMS2, regulates the termination of 
mismatch-stimulated DNA excision (Li, 2008).  
5.1 Mismatch repair and the UPS 
The UPS is involved in post-transcriptional regulation of hMutS┙ protein expression 
(Humbert et al., 2002; Hernandez-Pigeon et al., 2004). Ubiquitination and degradation rates 
of hMSH2 and hMSH6 appear quite similar, suggesting that UPS-mediated proteolysis may 
maintain a constant ratio of these two proteins (Hernandez-Pigeon et al., 2004). While no 
strong correlation between total proteasomal activity and the degradation rate of hMutS┙ 
has been observed in vitro, low hMutS┙ expression in cells is a limiting factor for MMR and 
indicative of proteolytic activity of the UPS in MMR regulation (Ciechanover, 1994; 
Humbert et al., 2002; Hernandez-Pigeon et al., 2004). This process is regulated also by an 
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atypical protein kinase C ┞ (PKC┞); this kinase increases hMutS┙ protein levels and the 
binding of hMutS┙ to GT mismatches (Hernandez-Pigeon et al., 2005). Essentially, PKC┞ 
expression and ubiquitination of hMutS┙ proteins are inversely related, and PKC┞ kinase 
activity interferes in the UPS-mediated degradation of hMutS┙ (Hernandez-Pigeon et al., 
2005). Collectively, these results support a model in which PKC┞ serves as a positive 
regulator for UPS-mediated MMR by directly interacting with the hMutS┙ complex. There is 
also evidence of hMutS┙ protein sumoylation, but the functional importance of this  is 
unclear (Hernandez-Pigeon et al., 2005). 
Human exonuclease I (hEXO1) complexes with hMutL┙ and functions in the excision step of 
MMR (Schmutte et al., 2001; Genschel et al., 2002). In response to DNA replication arrest, the 
isoform hEXO1b is polyubiquitinated and degraded, and phosphorylation of hEXO1b 
correlates with its UPS-mediated degradation (El-Shemerly et al., 2005).  
6. Double-strand break repair 
DNA double-strand breaks (DSBs) can be lethal to cells predominantly because the most 
important DSB repair process, non-homologous end joining (NHEJ), is error-prone, leaving 
mutations in the DNA following repair. Two possible repair processes that correct DSBs are 
homologous recombination (HR) and NHEJ. HR repair exchanges nucleotide sequences 
between two homologous chromosomes; this leads to error-free repair of DSB damage, 
preventing mutagenesis (Li et al., 2000). During the initial stages of mammalian HR, the 
MRN complex, composed of Mre11-Rad50-Nbs1, recognizes and carries out initial 
processing of the broken DNA ends. Following DSB resection, single-stranded DNA ends 
are bound by Rad51, Rad52, and RPA (Zhao et al., 2007). Strand invasion and displacement 
to initiate repair synthesis from the homologous sequence are mediated by Rad51, Rad54, 
Brca1, and Brca2, and HR is completed upon DNA annealing and ligation (Li & Heyer, 
2008). NHEJ is a rapid, error-prone pathway that does not necessarily restore the sequence 
around the DSB, leading to local deletions and chromosomal translocations. NHEJ is the 
predominant form of DSB repair in mammalian cells because it occurs in the G0-, G1-, and 
early S-phases of the cell-cycle (before duplication of the DNA). The Ku70/Ku80 
heterodimer detects the exposed ends of DNA DSBs in NHEJ and then recruits and forms a 
holoenzyme with DNA-dependent protein kinase (DNA-PK) to sense and to repair 
damaged DNA (Gottlieb & Jackson, 1993; Downs & Jackson, 2004). The MRN complex also 
influences NHEJ, and Xrcc4 and ligase IV complete the resealing reaction.  
6.1 Double-strand break repair and the UPS 
Crosslinking and chromatin immunoprecipitation studies reveal that subunits of the 26S 
proteasome are recruited to DSB sites, suggesting that proteolysis takes place concurrent 
with DSB repair (Krogan et al., 2004). Both NHEJ and HR are affected by interaction with 
the proteasome, such as through DNA polymerase IV (Pol4) and Rad52, respectively (Tseng 
& Tomkinson, 2002; Krogan et al., 2004). Rad52 forms multimeric ring foci, which are 
centers of recombination repair capable of processing multiple DNA lesions (West, 2003). 
Other HR proteins depend on the presence of Rad52 and its interaction with ssDNA regions 
in HR repair for their function (West, 2003). In yeast, one of the proteins associated with 
Rad52 is Sem1, a component of the yeast 19S proteasome. In the absence of Rad52, 
recruitment of Sem1 to damaged DNA is reduced (Krogan et al., 2004). Moreover, knock-out 
of Sem1 in yeast strains capable of only HR or NHEJ, but not both, results in impaired cell 
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growth. Therefore, Sem1 and the proteasome are crucial for HR DSB repair (Krogan et al., 
2004). The human homolog of Sem1, Deleted in Split hand/Split foot 1 (DSS1), is a part of 
the human 19S proteasome and involved in HR through interaction with Brca2 (Marston et 
al., 1999). Just as knock-out of Brca2 increases dependence of HR on mammalian Rad52 
(West, 2003), depletion of DSS1 in human cells significantly reduces HR activity, while 
treatment with proteasome inhibitors corresponds to a smaller decrease in HR (Kristensen et 
al., 2010). Thus, it is likely that DSS1 engages in functions in HR other than strictly 
proteolysis (Kristensen et al., 2010).  
DSS1 and Brca2 interact with Rpn3 and Rpn7, though the Brca2/Rpn7 interaction does not 
depend on DSS1 (Gudmundsdottir et al., 2007). On the contrary, it is Brca2 that secures the 
presence of the proteasome close to DNA repair machinery. Upon treatment of an ES cell 
line with the proteasome inhibitor epoxomicin, Gudmundsdottir and colleagues observed a 
shift in the repair of repetitive elements from the error-free gene conversion pathway to the 
error-prone single-strand annealing pathway. This suggests that the proteasome plays a 
functional role in support of HR as a repair mechanism of DSBs (Gudmundsdottir et al., 
2007).  
As mentioned previously, knock-out of different proteasomal subunits or proteosome 
inhibition by small molecules interferes with both HR and NHEJ in yeast (Krogan et al., 
2004); in higher eukaryotes, association of NHEJ and proteosome appears to be less 
obligatory. Here, proteasome inhibitors MG132 and LC reduce HR-dependent DSB repair 
but only marginally affect NHEJ-mediated repair of an artificial substrate (Murakawa et al., 
2007). MG132 treatment of Ku70-deficient chicken DT40 cells, which are impaired in NHEJ 
but not in HR, negatively affects the repair kinetics of ionizing radiation-induced DSBs. 
However, MG132 treatment of Rad54-deficient chicken DT40 cells, impaired in HR but not 
in NHEJ, does not delay DSB repair. Ionizing radiation-induced Brca1 and Rad51 foci 
formation in HeLa cells is reduced upon treatment with MG132. Therefore, it appears as if 
the proteasome functions at an early step of HR, prior to formation of the Brca2-DSS1 
complex (Murakawa et al., 2007).  
Brca1 contains a RING domain, which is generally associated with ubiquitin-protein ligase 
activity (Starita & Parvin, 2003). Human C-terminal binding protein interacting protein 
(CtIP), which regulates DSB resection and efficient HR, is ubiquitinated when it associates 
with chromatin following DNA damage. This ubiquitination of CtIP is catalyzed by Brca1 
and is not a degradation signal (Yu et al., 2006; Sartori et al., 2007). Brca1 dimerizes with 
Bard1 to elicit higher ubiquitin-protein ligase activity than either Brca1 or Bard1 alone 
(Hashizume et al., 2001; Xia et al., 2003). These two proteins appear to stabilize one another 
in vivo, suggesting that each does not participate in the degradation of the other (Hashizume 
et al., 2001; Xia et al., 2003). Brca1/Bard1 assemble polyubiquitin chain linkages through 
non-K48 residues, mostly through K63, indicative of non-proteolytic function (Chen et al., 
2002). The Brca1/Bard1 complex is capable of autoubiquitination in vitro and in vivo, and it 
also mediates monoubiquitination of histone H2A/H2AX in vitro (Chen et al., 2002). At a 
higher level of complexity, Brca1/Bard1, Rap80, which has two domains that bind K63-
linked ubiquitin chains, the DUB Brcc36, and Abraxas form a complex that localizes to 
damaged DNA (Wang & Elledge, 2007). Ubc13, an E2 enzyme, and Rnf8, a Ubc13-associated 
E3 enzyme, which together catalyze K63-linked ubiquitin chains at DSBs, are both required 
for Rap80 and Abraxas foci formation induced by ionizing radiation (Huen et al., 2007; 
Kolas et al., 2007; Wang & Elledge, 2007). The interaction between Rap80 and Abraxas 
localizes Brca1 and the DUB Brcc36 to ionizing radiation-induced foci (Wang & Elledge, 2007).  
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In conducting studies revolving around the sensitivity of Ubc13-deficient cells to DNA-
damaging agents, Zhao and co-workers discovered a link between Ubc13 and HR in higher 
eukaryotes. Mammalian cells depleted of Ubc13 demonstrate defective HR following 
ionizing radiation (Zhao et al., 2007). This observation corresponds with impaired 
recruitment of Rad51 to DSBs, reduced Brca1 ubiquitin-protein ligase activity and foci 
formation, and decreased accumulation of RPA single-strand binding protein at DNA 
lesions. NHEJ, however, appears to function normally in Ubc13 null cells. The role of Ubc13 
in HR does not appear to involve PCNA ubiquitination, thereby distinguishing the role of 
Ubc13 in HR from its activities in post-replication repair (PRR). Nevertheless, the 
mechanism of Ubc13-promoted DSB resection requires further investigation (Zhao et al., 
2007).  
The E3 ubiquitin-protein ligase, Rnf8, a modulator of the DNA damage response, mediates 
histone ubiquitination and allows DSB-flanking chromatin to accumulate additional DNA 
damage regulators (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 2007; Wang & 
Elledge, 2007; Doil et al., 2009). In particular, Rnf8 is required for accumulation of 53BP1 and 
Brca1 following ionizing radiation (Huen et al., 2007; Kolas et al., 2007; Mailand et al., 2007; 
Sakasai & Tibbetts, 2008). Following UV illumination, recruitment of 53BP1 partially 
depends on Ubc13 and Rnf8, and 53BP1 recruitment is suppressed upon proteasomal 
inhibition (Sakasai & Tibbetts, 2008). Importantly, 53BP1-deficient cells exhibit defects in 
NHEJ (Nakamura et al., 2006). Rnf8 is the first E3 to assemble at DSBs and allows for the 
recruitment of another E3 ligase, Rnf168, which has two ubiquitin-binding domains. Rnf168 
appears to increase K63-linked ubiquitination at DSBs necessary to retain 53BP1 and Brca1 
(Doil et al., 2009). Stewart and co-workers identified Rnf168 as the gene mutated in RIDDLE 
Syndrome (Stewart et al., 2009), a disorder characterized in part by radiosensitivity and 
immunodeficiency. Cells derived from a RIDDLE patient fail to localize 53BP1 to DSBs 
(Stewart et al., 2007). Accordingly, these cells display decreased Brca1 foci formation, 
hypersensitivity to ionizing radiation, and irregular cell-cycle checkpoints (Stewart et al., 
2007; Stewart et al., 2009).  
With regard to UBLs, SUMO-1 is the most frequently involved in DSB repair; it forms stable 
complexes with Rad51, Rad52, and Rad51/Rad52 in co-immunoprecipitation experiments 
(Shen et al., 1996; Li et al., 2000). The role of SUMO-1 in HR appears to be inhibitory, as 
overexpression of SUMO-1 has been shown to measurably decrease radioresistance and 
bidirectional gene conversion tracts in mammalian cells (Li et al., 2000). Sumoylation of 
Rad52 is observed infrequently unless this modification of Rad52 is induced in a cell cycle- 
and lesion-specific fashion (Ohuchi et al., 2008). In yeast, Rad52 sumoylation appears to be 
triggered specifically by interactions with Rad50, Mre11 and Xrs2 (but not Rad51), members 
of the yeast homolog of the MRN complex, the MRX complex (Sacher et al., 2006; Ohuchi et 
al., 2008). There is conflicting evidence pertaining to the residues required for Rad52 
sumoylation, but self-association of Rad52 appears important for its sumoylation. 
Essentially, sumoylation of Rad52 appears to preserve Rad52 activity and to inhibit rapid 
degradation of the protein (Sacher et al., 2006).  
Two of the key NHEJ enzymes, Ku70 and Ku80, are susceptible to ubiquitination (Gama et 
al., 2006). Ku70 and Ku 80 are degraded by the proteasome, and MG132 delays proteolysis 
of these proteins (Postow et al., 2008; Enokido et al., 2010). Ubiquitinated Ku70 in human 
cells has been detected in the absence of proteasome inhibitors, indicating that this 
modification may not always serve as a degradation signal for Ku70; yet, apoptotic stress 
does upregulate degradative Ku70 ubiquitination (Gama et al., 2006). Ku70 and Ku80 
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stabilize one another, but ubiquitinated Ku70 appears to inhibit Ku70/Ku80 complex 
formation (Gama et al., 2006). Ku80 is polyubiquitinated when bound to DSBs in Xenopus 
laevis egg extracts, and this K48-linked polyubiquitination is related to removal of Ku80 
from DNA (Postow et al., 2008). However, polyubiquitination-induced removal of Ku80 
from DSBs is not required for the completion of NHEJ (Postow et al., 2008). In yeast, 
aberrant expression of key proteosome regulating transcription factor Rpn4 appears to 
hinder NHEJ but not HR (Ju et al., 2010). When proteosomal degradation of Rpn4 itself is 
inhibited, the expression levels of Ku70, Ku80, and Mre11 are decreased, as well as the 
accumulation of Ku70 at DSBs (Ju et al., 2010).      
Ubiquitination and levels of monoubiquitinated Xrcc4 increase upon etoposide-induced 
DNA damage (Foster et al., 2006). Xrcc4, however, is a stable protein, and treatment with 
proteasome inhibitors does not correlate with Xrcc4 accumulation, suggesting that this type 
of Xrcc4 modification serves a non-proteolytic function. This enzyme also stabilizes ligase 
IV, whose half-life also increases upon treatment with proteasome inhibitors (Foster et al., 
2006). Human Xrcc4 is also sumoylated in vitro and in vivo (Yurchenko et al., 2006). This 
modification regulates Xrcc4 localization; a non-sumoylated mutated Xrcc4 protein 
accumulates in the cytoplasm rather than in the nucleus (Yurchenko et al., 2006). This 
mutant protein causes radiosensitivity, but fusion of SUMO to its C-terminus leads to 
nuclear Xrcc4 localization and radiation resistance of cells with this genotype (Yurchenko et 
al., 2006).   
7. Post-replication repair 
Post-replication repair (PRR), also known as DNA damage tolerance or damage bypass, is a 
process that fills gaps formed in newly synthesized single-stranded DNA. This type of 
repair is essential for avoiding unrepaired DSBs, such as those that result from the 
prolonged stalling of DNA replication forks (Podlaska et al., 2003; Zhuang et al., 2008). PRR 
operates by either an error-free or an error-prone mechanism. The error-free/damage 
avoidance pathway involves HR or template switching to the undamaged sister chromatid 
(Lee & Myung, 2008; Ulrich, 2009). The error-prone method, referred to as DNA translesion 
synthesis (TLS), is carried out by a TLS polymerase such as Pol ┞, Pol ┟, Pol ┡, Pol ┢, or Rev1 
(Prakash et al., 2005). Rad6, an E2 enzyme, and Rad18, a DNA-binding protein, form a 
complex that governs PRR and is responsible for PCNA modification, a crucial event in this 
DNA repair pathway (Hoege et al., 2002; McIntyre et al., 2006).  
7.1 Post-replication repair and the UPS 
Proteasome inhibitors have been shown to disrupt TLS in cancer cells by delaying cisplatin 
and UV-induced translesion reactions (Takezawa et al., 2008). Studies of defective 20S 
proteasomal activity in yeast strains have revealed important relationships between the UPS 
and PRR. The Ump1 proteasomal maturase is required for processing of the ┚-subunits and 
proper assembly of the 20S proteasome (Ramos et al., 1998). Deletion of Ump1 or of the 
genes encoding the ┚2- and ┚5-subunits of the 20S proteasome, Pup1 and Pre2, respectively, 
correlates with an increase in UV-sensitivity and spontaneous mutagenesis. Importantly, 
this phenotype is characteristic of yeast strains with defects in PRR, and Podlaska and 
colleagues have determined that these genes are members of the Rad6/Rad18 epistasis 
group (Podlaska et al., 2003). This spontaneous mutator phenotype has been verified to be 
primarily PRR-based and unrelated to the HR and NER pathways (McIntyre et al., 2006).  
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Knock-out of Rev3, which encodes the catalytic subunit of Pol ┞, in an Ump1-deficient yeast 
strain correlates with a dramatic decrease in the frequency of UV-induced and spontaneous 
mutations, thereby suggesting that Ump1 may serve as a negative regulator of Rev3 
(Podlaska et al., 2003; McIntyre et al., 2006; Wiltrout & Walker, 2011). In contrast, the 
presence of Rad30, which encodes Pol ┟, in an Ump1-deficient background is associated with 
increased UV-sensitivity but a decrease in the frequency of spontaneous mutations 
(Podlaska et al., 2003; McIntyre et al., 2006). Taken together, these results suggest that Rev3 
and Rad30 are epistatic to Ump1 and that mutations caused by proteasomal defects depend 
upon both Pol ┞ and Pol ┟ (Podlaska et al., 2003; McIntyre et al., 2006). Rad30 is a short-lived 
protein post-translationally regulated by the UPS (Skoneczna et al., 2007). Its degradation 
depends on the Skp1/Cullin/F-box E3 enzyme complex and the Ufo1 F-box protein 
(Skoneczna et al., 2007). Rev1 is also a relatively short-lived protein but has a longer half-life 
during G2/M-phases than G1-phase, potentially implicating proteasomal regulation. In 
support of this idea, Rev1 levels are elevated upon treatment with proteasome inhibitors or 
in an Ump1-deficient background (Wiltrout & Walker, 2011).     
Ubiquitin is essential for the regulation, localization, and stability of Rad18 PRR protein 
(Ulrich, 2009). In response to DNA damage, Rad18 autoubiquitination indirectly regulates 
PRR by balancing levels of unmodified Rad18 in the nucleus and monoubiquitinated Rad18 
in the cytoplasm (Miyase et al., 2005). Polyubiquitinated Rad18 is not present under normal 
conditions, potentially because it is subject to rapid degradation. However, 
polyubiquitinated Rad18 may be detected upon treatment with proteasome inhibitors or in 
an in vitro system consisting of Rad18, one E1 enzyme, Rad6, and ubiquitin (Miyase et al., 
2005).  
Rad18 also influences PCNA monoubiquitination following DNA damage (Hoege et al., 
2002; Stelter & Ulrich, 2003; Kannouche et al., 2004). Monoubiquitinated PCNA is thought to 
promote the error-prone TLS pathway, while polyubiquitinated PCNA may regulate the 
error-free damage avoidance pathway (Hoege et al., 2002; Stelter & Ulrich, 2003; Kannouche 
et al., 2004; Watanabe et al., 2004). Monoubiquitinated PCNA is thought to facilitate 
targeting of Pol ┟ to DNA damage sites and is required for the replacement of stalled Pol ├ 
by Pol ┟ (Kannouche et al., 2004; Watanabe et al., 2004; Zhuang et al., 2008). In response to 
DNA damage, Pol ┟ and Pol ┡ also noncovalently interact with ubiquitin and 
monoubiquitinated PCNA (Bienko et al., 2005; Plosky et al., 2006). Pol ┟ and Pol ┡ mutants 
lacking the ability to bind ubiquitin demonstrate downregulated levels of DNA damage-
induced replication foci; this suggests that the polymerase-ubiquitin interaction may be an 
important component in the recruitment of TLS polymerases to stalled replication forks 
(Plosky et al., 2006). Ubiquitinated PCNA also substantially activates Pol ┟ and Rev1 in vitro 
(Garg & Burgers, 2005). Unmodified PCNA stimulates Pol ┞-mediated TLS, and no 
significant differences in this type of TLS are observed upon substitution of unmodified 
PCNA with ubiquitinated PCNA (Garg & Burgers, 2005; Garg et al., 2005). Thus, 
ubiquitinated PCNA has different functional interactions with the various TLS polymerases.  
Importantly, it appears as if ubiquitination of, rather than sumoylation of, PCNA 
contributes to the observed spontaneous mutator phenotype associated with proteasomal 
defects (McIntyre et al., 2006). An important role for sumoylation of PCNA seems to be in 
preventing unscheduled HR during S-phase (Papouli et al., 2005; Pfander et al., 2005). 
Nevertheless, recent studies suggest that PCNA sumoylation may be required for the 
stimulation of TLS in addition to the presence of monoubiquitinated PCNA (Halas et al., 
2011). In the case of PCNA, SUMO and ubiquitin appear to cooperatively rather than 
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competitively coordinate the choice in DNA repair pathways of replication lesions (Plosky 
et al., 2006).   
8. Fanconi anemia  
Fanconi anemia (FA) is a rare autosomal recessive and X-linked genetic disorder 
characterized in part by congenital deformities, bone marrow failure, and elevated risk of 
cancer. FA is associated with hypersensitivity to DNA crosslinking agents, and treatment of 
FA cells with such agents (mitomycin C, for example) leads to chromosomal instability and 
cell death (Heinrich et al., 2000). 13 FA complementation groups have been identified 
(FANCA, B, C, D1, D2, E, F, G, I, J, L, M, and N), and disruption of any one of the genes 
named after these complementation groups causes FA. Proposed roles for the FA pathway 
include involvement in circumventing stalled replication forks, HR, TLS, enzymatic DNA 
processing, and cell-cycle regulation (Kennedy & D'Andrea, 2005; Pang & Andreassen, 2009; 
Kratz et al., 2010).  
8.1 Fanconi anemia and DNA repair   
At least 8 of the FA complementation groups (FANCA, B, C, E, F, G, L, and M) and two 
associated proteins, FAAP24 and FAAP100, form an E3 enzyme complex required for 
monoubiquitination of FANCD2 (Ciccia et al., 2007; Ling et al., 2007). Loss of any subunit of 
this FA core complex negatively alters complex formation and prevents FANCD2 
monoubiquitination (Huang & D'andrea, 2006). Specifically, monoubiquitination of 
FANCD2 occurs at K561 during S-phase during normal cell-cycle progression as well as 
following DNA damage (Kennedy & D'Andrea, 2005). The latter event is linked to FANCD2 
localization to chromatin and colocalization with other DNA damage signalling proteins 
such as FANCD1, Brca2, Rad51, Nbs1, and PCNA (Kennedy & D'Andrea, 2005; Nijman et 
al., 2005). FANCL is capable of autoubiquitination in vitro and is required for 
monoubiquitination of FANCD2 and its relocation to damage-associated nuclear foci, 
suggesting that FANCL is the catalytic component of the FA core complex (Meetei et al., 
2003; Huang & D'andrea, 2006). Brca1 has the potential to serve as an E3 enzyme for 
FANCD2 in vitro, but genetic evidence hints that Brca1 is not required for FANCD2 
monoubiquitination (Vandenberg et al., 2003). Instead, Brca1 may modulate 
monoubiquitination of FANCD2 or the stability of the modified protein (Meetei et al., 2003). 
UBE2T, which directly binds FANCL, is the E2 enzyme involved in monoubiquitination of 
FANCD2 (Machida et al., 2006). UBE2T engages in a negative feedback loop, commencing 
self-inactivation by automonoubiquitination in vivo (Machida et al., 2006). RPA1 and ATR 
are required for efficient FANCD2 monoubiquitination, and ATM is not necessary in this 
process (Andreassen et al., 2004). Similarly, silencing of ATR, but not of ATM, suppresses 
FANCD2 foci formation following exposure of cells to DNA crosslinking agents 
(Andreassen et al., 2004). As with PCNA, the DUB Usp1 associates with and regulates 
monoubiquitination of FANCD2, and Usp1 inhibition increases FANCD2 
monoubiquitination (Nijman et al., 2005).  
FANCD2 and FANCI share sequence homology (Smogorzewska et al., 2007). Small 
interfering RNAs (siRNAs) directed against FANCD2, FANCI, and FANCA suppress HR, 
suggesting a role of these proteins in the DSB repair pathway. Like FANCD2, FANCI is 
ubiquitinated following DNA damage or during normal S-phase. These two enzymes form a 
complex, known as ID, which dictates FANCD2 localization in damage-associated nuclear 
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foci. FANCD2 and FANCI are interdependent in that ubiquitin modification of each protein 
is dependent upon ubiquitin modification of the other (Smogorzewska et al., 2007). FANCI 
also restricts monoubiquitination of FANCD2 to the correct lysine residue in vivo (Alpi et al., 
2008). FANCD2-ubiquitin and FANCD2-histone H2B fusion proteins harbouring an arginine 
substitution to remove the monoubiquitin site of FANCD2 have been shown to colocalize to 
chromatin and to reverse DNA-crosslink hypersensitivity of FANCD2-deficient cells 
(Matsushita et al., 2005). However, these fusion proteins do not complement FANCC-, 
FANCG-, or FANCL-deficient cells, suggesting that the members of the FA core complex 
play roles outside that of monoubiquitination and chromatin targeting of FANCD2 
(Matsushita et al., 2005). The link between monoubiquitination of FANCD2/FANCI and 
recruitment of the ID complex to chromatin remains unclear (Al-Hakim et al., 2010). Recent 
findings surrounding the FANCD2-associated nuclease KIAA1018/FAN1 provide valuable 
information regarding the functional importance of ID complex ubiquitination. FAN1 is a 
conserved protein with an N-terminal ubiquitin-binding zinc finger (UBZ) and a C-terminal 
nuclease domain (Kratz et al., 2010; Liu et al., 2010; MacKay et al., 2010; Smogorzewska et 
al., 2010). FAN1 interacts with FANCD2 and FANCI, and loss of FAN1 is associated with 
hypersensitivity to and defective repair of intrastrand crosslinks. The UBZ of FAN1 targets 
the protein to damage-induced nuclear foci since deletion of the UBZ prevents FAN1 from 
accumulating at sites of damage (Kratz et al., 2010; Liu et al., 2010; MacKay et al., 2010; 
Smogorzewska et al., 2010). Importantly, this recruitment of FAN1 is dependent upon 
interaction of its UBZ domain with monoubiquitinated FANCD2. Although the mechanism 
of FAN1 is still being elucidated, it will be interesting to determine whether other factors 
which also recognize ID complex monoubiquitination are recruited to sites of damage by 
crosslinking agents (Al-Hakim et al., 2010).  
9. Proteasome inhibitors and DNA repair 
Proteasome inhibitors include synthetic molecules and natural products (Groll et al., 2009). 
Most small molecule proteasome inhibitors are peptide derivatives that bind to the 
proteolytic active sites of the 20S proteasome (Huang & Chen, 2009). Specifically, 
bortezomib (PS-341, Velcade) is a dipeptidyl boric acid that selectively and reversibly 
inhibits the ┚5-subunit of the 20S with high affinity (Berkers et al., 2005). Clinically, 
bortezomib administration results in tumor shrinkage through events such as cellular 
growth arrest, increased apoptosis, and decreased angiogenesis (Russo et al., 2007; Gilardini 
et al., 2008). The mechanisms by which bortezomib exerts its effects, however, remain 
controversial. It has been shown that bortezomib stabilizes p21, p27, p53, proapoptotic 
proteins such as Bid and Bax, and the transcription factor Myc (McConkey & Zhu, 2008; 
Orlowski & Kuhn, 2008). Inhibition of NF-┢B and of anti-apoptotic proteins, generation of 
reactive oxygen species (ROS), and increases in endoplasmic reticulum (ER) stress have also 
been implicated by some and repudiated by others as potential bortezomib-stimulated 
outcomes (Chen et al., 2010). Nevertheless, although the exact mechanisms of bortezomib-
induced cell death remain inconclusive, current research hints at a role of DNA repair in this 
process.  
Bortezomib has been shown to enhance the DNA damage response. In a genome-wide 
siRNA screen to identify genetic components linked to bortezomib-induced cell death, 
knockdown of proteins responsible for HR was found to be protective against cell death 
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(Chen et al., 2010). Bortezomib treatment leads to stabilization of Rad51, upregulation of 
ATM-dependant phosphorylation of H2AFX, CHK2, SMC1A, and TP53 and of ATR-
dependent phosphorylation of CHK1, as well as increased monoubiquitination of FANCD2 
(Chen et al., 2010). Bortezomib has also been shown to inhibit basal and DNA damage-
induced monoubiquitination of FANCD2 but not of PCNA (Jacquemont & Taniguchi, 2007).  
A phase 3 clinical trial of bortezomib with melphalan and prednisone, the standard 
treatment of multiple myeloma patients, is currently ongoing with patients who cannot 
receive high-dose therapy (Chen et al., 2005; San Miguel et al., 2008). HR and FA are thought 
to be required for resistance to melphalan, a chemotherapeutic DNA alkylating agent, and 
bortezomib plus melphalan and prednisone produces outcomes greater than melphalan-
prednisone alone (Wang et al., 2001; Chen et al., 2005). Since bortezomib appears to interfere 
with DNA-damage signaling, sensitization of cancer cells to melphalan and prednisone 
coud be due to the influence of the proteasome on one or more DNA repair pathway(s). 
Treatment of cells first with ionizing radiation or DNA crosslinking agents and secondly 
with bortezomib delays formation of phospho-ATM, 53BP1, Nbs1, and Brca1 foci and 
inhibits formation of FANCD2 and Rad51 foci. However, ┛-H2AX, MDC1, and RPA foci are 
unaffected by these treatments, suggesting that early DNA damage signaling remains intact 
in these cells. This and similar results found using the proteasome inhibitors MG132 and 
epoxomicin (Jacquemont & Taniguchi, 2007; Takeshita et al., 2009) again suggest the 
requirement for UPS in DNA repair progression.  
10. Conclusion 
Here, we have summarized some of the current understanding of the relation of UPS to 
NER, BER, MMR, DSB, PRR, and FA repair. However, the influence of the UPS on DNA 
repair is not restricted to these repair mechanisms, as evidence suggests that the UPS also 
affects pathways beyond the scope of this review, such as direct repair by MGMT (O6-
methylguanine-DNA methyltransferase) (Vlachostergios et al., 2009a). Much evidence 
shows that the UPS is a potent regulator of repair following DNA damage. It will no doubt 
be interesting and beneficial to expand our knowledge of the UPS and DNA repair by using 
proteasome inhibitors such as bortezomib in conjunction with different chemotherapeutic 
and irradiation treatments.  
The obligatory cooperation between DNA repair and UPS is clearly preserved throughout 
eukaryotic evolution (Daulny & Tansey, 2009); upon consideration, this is a very logical 
example of the interdependence of seemingly disparate biological systems. Sequential 
enzymatic activity is a hallmark of well-regulated biological processes. In DNA repair, it 
appears in many cases that replacement of one enzyme with another depends on its tightly 
regulated proteolysis or other UPS-mediated modification (Hardeland et al., 2002a; 
Steinacher & Schar, 2005a; Parsons et al., 2008a). The UPS has the necessary degree of 
control to execute the proteolysis in a manner required, enabling the repair processes to 
advance through different stages. A well-orchestrated activity of the two processes suggests 
that DNA repair and the UPS have co-evolved to provide living organisms with a way to 
cope with environmental DNA injuries. Increasingly complex UPS-mediated regulation of 
multifunctional repair enzymes such as PCNA, coinciding with evolution of higher 
eukaryotes, further supports this notion. 
It is interesting to note that DNA repair in prokaryotes, where there is no proteasome 
system, is regulated predominantly at the transcriptional level (Friedberg, 1996). This 
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regulation often involves the removal of a single protein (a transcriptional repressor), which 
allows for a particular operon to be expressed. In eukaryotes, while there are a few DNA 
repair proteins that are transcriptionally regulated (for example, PCNA and DNA 
polymerase most DNA repair is regulated at the level of post-translational modifications 
such as phosphorylation, acetylation, protein complex formation, as well as 
monoubiquitination, polyubiquitination, sumoylation, etc. (Vlachostergios et al., 2009b; 
Vlachostergios et al., 2009a). The removal of specific proteins is needed for the DNA repair 
process progression in eukaryotic cells, but this removal in eukaryotes is more complex than 
the repressor system of DNA repair regulation prokaryotes—it requires the complex UPS to 
regulate protein accumulation and turnover (Motegi et al., 2009). It is possible that the 
expansion of the eukaryotic genome to contain large numbers genes on several 
chromosomes made it necessary for proteasome complexes to co-exist and control DNA 
repair protein quantities at the level of protein degradation.  
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